Sunday, May 26, 2019 • 15:00 - 16:30
Track 5 - Dime Bags and Weed: Timely Tox Topics
Track Chair: Dr. Nancy Murphy
Room: 202

LO20 - Naloxone dosing for suspected opioid and ultra-potent opioid overdoses: A systematic review - Dr. Jessica Moe

LO21 - One-year mortality of patients treated in the emergency department for an opioid overdose: a single-centre retrospective cohort study - Mr. Andy Jiang

ED Interventions for Opioid Substance Use Disorder - Dr. Nancy Murphy

Description: This talk will provide specific and evidence-based guidance for managing patients with opioid use disorder in the ED. Topics covered will include specifics on supportive care and symptom management, buprenorphine, and proper discharge instructions.

Learning Objectives
At the end of this presentation, participants will be able to:

  1. Be familiar with the evidence supporting ED-initiated opioid agonist therapy and understand the necessary culture change required to accept this option.
  2. Identify patients who are appropriate for ED- initiated opioid agonist therapy and describe the approach to initiating buprenorphine in the ED.
  3. Know the indications, dosing, and possible adverse events for non-opioid treatments in opioid withdrawal.

Pearls

  1. ED-initiated buprenorphine reduces opioid-related mortality; EDs are well positioned to optimize the small window of opportunity for intervention.
  2. Patients must be in moderate to severe withdrawal at the time of buprenorphine initiation as per the COWS scale.
  3. Discharge instructions must include naloxone kit, specific buprenorphine dosing advice, and clear follow up plan.

Dr. Murphy is an emergency physician and medical toxicologist in Halifax, Nova Scotia. A native of Quebec City, she has dusted off her French language skills to provide on -call toxicologic consultation to the talented team at the Centre Anti-Poison du Québec and is Medical Director of the IWK Regional Poison Centre for the Atlantic provinces.

Cannabis in the ED: Current Issues and Best Evidence for Management - Dr. Neil Petrie

Description: In this session attendees will briefly review cannabis-associated health problems and their management, and current therapeutic indications. Attendees will be provided with information to help them develop their own position regarding cannabis legislation, and recommendations to their patients.

Learning Objectives
At the end of this presentation, participants will be able to:

  1. Identify the common ED presentations associated with cannabis use.
  2. Review of literature regarding the epidemiology and management of cannabis-associated health problems.
  3. Develop an understanding of current legislation regarding cannabis use.